Current Diabetes Reports

, 11:445

The Past, Present, and Future of Genetic Associations in Type 1 Diabetes

Authors

  • Peter R. BakerII
    • The Barbara Davis Center for Childhood DiabetesUniversity of Colorado Denver
    • The Barbara Davis Center for Childhood DiabetesUniversity of Colorado Denver
Article

DOI: 10.1007/s11892-011-0212-0

Cite this article as:
Baker, P.R. & Steck, A.K. Curr Diab Rep (2011) 11: 445. doi:10.1007/s11892-011-0212-0

Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disease affecting approximately one in 300 individuals in the United States. The majority of genetic research to date has focused on the heritability that predisposes to islet autoimmunity and T1DM. The evidence so far points to T1DM being a polygenic, common, complex disease with major susceptibility lying in the major histocompatibility complex (MHC) on chromosome 6 with other smaller effects seen in loci outside of the MHC. With recent advances in technology, novel means of exploring the human genome have given way to new information in the development of T1DM. The newest technologies, namely high-throughput polymorphism typing and sequencing, have led to a paradigm shift in studying common diseases such as T1DM. In this review we highlight the advances in genetic associations in T1DM in the last several decades and how they have led to a better understanding of T1DM pathogenesis.

Keywords

Type 1 diabetes Autoimmune diseases Major histocompatibility complex Human leukocyte antigen Genetic association study Linkage study Candidate gene Extended haplotype Single nucleotide polymorphism Genome-wide association study Whole exome sequencing

Copyright information

© Springer Science+Business Media, LLC 2011